Terlipressin group (n = 50) | Placebo group (n = 50) | P value | |
---|---|---|---|
Age (years) | 55.8 ± 6.0 | 54.4 ± 5.6 | 0.26 |
Gender (M/F) (n) | 40/10 | 43/7 | 0.44 |
Weight (kg) | 71.8 ± 7.3 | 74.0 ± 8.6 | 0.17 |
Height (cm) | 160.5 ± 5.7 | 158.6 ± 6.3 | 0.10 |
Ejection Fraction | 52.8 ± 8.0 | 50.6 ± 6.9 | 0.14 |
Euro score II | 1.1 ± 0.4 | 1.2 ± 0.3 | 0.36 |
Hypertension (n) | 33 | 28 | 0.32 |
Diabetes mellitus (n) | 21 | 26 | 0.42 |
Left main disease (n) | 10 | 13 | 0.64 |
No. of diseased coronaries (2/3) | 20/30 | 17/33 | 0.54 |
Losartan dose (mg/d) | 52 ± 26.6 | 53.5 ± 32.3 | 0.80 |
β-blocker (n) | 43 | 46 | 0.36 |
Calcium channel blocker (n) | 7 | 5 | 0.76 |
Nitrate (n) | 40 | 42 | 0.61 |
Diuretic (n) | 9 | 11 | 0.63 |